Vol 49 No 11

"We increasingly see the evolving role of ‘precision medicine’ in urology, using genetic and genomic testing to guide [management] for a variety of diseases, particularly bladder and prostate cancer," says 1 urologist.

"As always, document well and use the modifiers when appropriate," advise Jonathan Rubenstein, MD, and Mark Painter.

"This study provides credible support for the expectation that post-RC HRQOL should recover and improve over the first 2 years after RC, and provides a benchmark for comparisons with future bladder preservation strategies," writes Badar M. Mian, MD.

"The short answer is that this will be paid once," according to Jonathan Rubenstein, MD, and Mark Painter.

"Spend a few extra minutes to learn about emotions and voiding in your patient," writes Gopal H. Badlani, MD.

“Our study provides important findings that help to address the lack of data in Black/African American patients who are disproportionally affected by prostate cancer,” said Neal D. Shore, MD.

"Although the effects of a plant-based diet on the cardiovascular system and endocrine system are well-documented and very well-studied, the effect on erectile function [is not fully understood]," says Ruben Blachman-Braun, MD.

These compensatory behaviors are associated with more severe urinary symptoms and higher anxiety and stress.

“In a real-world clinical setting, providers representing a broad range of practice styles, settings, education, and experience readily adopted IsoPSA to help risk stratify and generated about a 50% reduction in the number of prostate biopsies recommended,” said Eric A. Klein, MD.